Monday, December 23, 2024
HomeTagsVaccinex

Vaccinex

Vaccinex Announces Pricing of $9.6 Million Public Offering

Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D,  announced it has...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics